Cargando…
Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes
BACKGROUND: Mutations in the Planar Cell Polarity (PCP) core gene Vangl2 cause the most severe neural tube defects (NTD) in mice and humans. Genetic studies show that the Vangl2 gene genetically interacts with a close homologue Vangl1. How precisely Vangl2 and Vangl1 proteins interact and crosstalk...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460870/ https://www.ncbi.nlm.nih.gov/pubmed/23029439 http://dx.doi.org/10.1371/journal.pone.0046213 |
_version_ | 1782245001769517056 |
---|---|
author | Belotti, Edwige Puvirajesinghe, Tania M. Audebert, Stéphane Baudelet, Emilie Camoin, Luc Pierres, Michel Lasvaux, Lea Ferracci, Géraldine Montcouquiol, Mireille Borg, Jean-Paul |
author_facet | Belotti, Edwige Puvirajesinghe, Tania M. Audebert, Stéphane Baudelet, Emilie Camoin, Luc Pierres, Michel Lasvaux, Lea Ferracci, Géraldine Montcouquiol, Mireille Borg, Jean-Paul |
author_sort | Belotti, Edwige |
collection | PubMed |
description | BACKGROUND: Mutations in the Planar Cell Polarity (PCP) core gene Vangl2 cause the most severe neural tube defects (NTD) in mice and humans. Genetic studies show that the Vangl2 gene genetically interacts with a close homologue Vangl1. How precisely Vangl2 and Vangl1 proteins interact and crosstalk has remained a difficult issue to address, with the main obstacle being the accurate discrimination of the two proteins, which share close sequence homology. Experimental evidence previously presented has been sparse and addressed with ectopically expressed proteins or with antibodies unable to biochemically discriminate Vangl1 from Vangl2, therefore giving rise to unclear results. METHODOLOGY AND MAIN FINDINGS: A highly specific monoclonal anti-Vangl2 antibody was generated and rigorously tested on both recombinant and extracted Vangl2 using surface plasmon resonance (SPR) analysis, western blot, and immunoprecipitation experiments. This antibody efficiently affinity-purified Vangl2 from cell lysates and allowed the unambiguous identification of endogenous Vangl2 by proteomic analysis. Vangl1 was also present in Vangl2 immunoprecipitates, establishing the first biochemical evidence for the existence of Vangl2/Vangl1 heterodimers at an endogenous level. Epitope-tagged Vangl2 and Vangl1 confirmed that both proteins interact and colocalize at the plasma membrane. The Vangl2 antibody is able to acutely assess differential expression levels of Vangl2 protein in culture cell lines, as corroborated with gene expression analysis. We characterised Vangl2 expression in the cochlea of homozygous and heterozygous Lp mutant mice bearing a point mutation within the C-terminal Vangl2 region that leads to profound PCP defects. Our antibody could detect much lower levels of Vangl2(Lp) protein in mutant mice compared to the wild type mice. CONCLUSION: Our results provide an in-depth biochemical characterisation of the interaction observed between Vangl paralogues. |
format | Online Article Text |
id | pubmed-3460870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-34608702012-10-01 Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes Belotti, Edwige Puvirajesinghe, Tania M. Audebert, Stéphane Baudelet, Emilie Camoin, Luc Pierres, Michel Lasvaux, Lea Ferracci, Géraldine Montcouquiol, Mireille Borg, Jean-Paul PLoS One Research Article BACKGROUND: Mutations in the Planar Cell Polarity (PCP) core gene Vangl2 cause the most severe neural tube defects (NTD) in mice and humans. Genetic studies show that the Vangl2 gene genetically interacts with a close homologue Vangl1. How precisely Vangl2 and Vangl1 proteins interact and crosstalk has remained a difficult issue to address, with the main obstacle being the accurate discrimination of the two proteins, which share close sequence homology. Experimental evidence previously presented has been sparse and addressed with ectopically expressed proteins or with antibodies unable to biochemically discriminate Vangl1 from Vangl2, therefore giving rise to unclear results. METHODOLOGY AND MAIN FINDINGS: A highly specific monoclonal anti-Vangl2 antibody was generated and rigorously tested on both recombinant and extracted Vangl2 using surface plasmon resonance (SPR) analysis, western blot, and immunoprecipitation experiments. This antibody efficiently affinity-purified Vangl2 from cell lysates and allowed the unambiguous identification of endogenous Vangl2 by proteomic analysis. Vangl1 was also present in Vangl2 immunoprecipitates, establishing the first biochemical evidence for the existence of Vangl2/Vangl1 heterodimers at an endogenous level. Epitope-tagged Vangl2 and Vangl1 confirmed that both proteins interact and colocalize at the plasma membrane. The Vangl2 antibody is able to acutely assess differential expression levels of Vangl2 protein in culture cell lines, as corroborated with gene expression analysis. We characterised Vangl2 expression in the cochlea of homozygous and heterozygous Lp mutant mice bearing a point mutation within the C-terminal Vangl2 region that leads to profound PCP defects. Our antibody could detect much lower levels of Vangl2(Lp) protein in mutant mice compared to the wild type mice. CONCLUSION: Our results provide an in-depth biochemical characterisation of the interaction observed between Vangl paralogues. Public Library of Science 2012-09-28 /pmc/articles/PMC3460870/ /pubmed/23029439 http://dx.doi.org/10.1371/journal.pone.0046213 Text en © 2012 Belotti et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Belotti, Edwige Puvirajesinghe, Tania M. Audebert, Stéphane Baudelet, Emilie Camoin, Luc Pierres, Michel Lasvaux, Lea Ferracci, Géraldine Montcouquiol, Mireille Borg, Jean-Paul Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes |
title | Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes |
title_full | Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes |
title_fullStr | Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes |
title_full_unstemmed | Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes |
title_short | Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes |
title_sort | molecular characterisation of endogenous vangl2/vangl1 heteromeric protein complexes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460870/ https://www.ncbi.nlm.nih.gov/pubmed/23029439 http://dx.doi.org/10.1371/journal.pone.0046213 |
work_keys_str_mv | AT belottiedwige molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes AT puvirajesinghetaniam molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes AT audebertstephane molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes AT baudeletemilie molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes AT camoinluc molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes AT pierresmichel molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes AT lasvauxlea molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes AT ferraccigeraldine molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes AT montcouquiolmireille molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes AT borgjeanpaul molecularcharacterisationofendogenousvangl2vangl1heteromericproteincomplexes |